Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
23.9%
% of HELX's 75 holdings also in BBH
64.0%
% of BBH's 27 holdings also in HELX
Overlap by Weight
Sector Drift (HELX minus BBH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HELX |
Weight in BBH |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 4.7% | 11.2% | 4.7% |
|
NATERA INC | 5.2% | 4.5% | 4.5% |
|
REGENERON PHARMACEUTICALS | 4.0% | 5.2% | 4.0% |
 |
BIONTECH SE SPONSORED ADR | 2.8% | 2.4% | 2.4% |
|
INSMED INC | 2.4% | 2.6% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
HELX Overweight Relative to BBH
|
KRYSTAL BIOTECH, INC. | 4.8% |
|
MEDPACE HOLDINGS, INC. | 3.6% |
|
ELI LILLY & CO | 3.5% |
 |
SAMSUNG BIOLOGICS CO., LTD. | 3.4% |
|
THERMO FISHER SCIENTIFIC INC | 3.4% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.0% |
|
UNITED THERAPEUTICS CORP | 2.8% |
|
CORTEVA INC | 2.6% |
|
SARTORIUS AG PREF | 2.3% |
|
DANAHER CORP | 2.2% |
HELX Underweight Relative to BBH
|
AMGEN INC | -16.1% |
|
GILEAD SCIENCES INC | -12.5% |
|
VERTEX PHARMACEUTICALS INC | -6.5% |
 |
ARGENX SE ADR | -5.1% |
|
BIOGEN IDEC INC | -3.4% |
|
IQVIA HOLDINGS INC | -3.4% |
 |
ICON PLC | -3.1% |
|
INTRA-CELLULAR THERAPIES INC | -2.9% |
|
ILLUMINA INC | -2.7% |
|
ALNYLAM PHARMACEUTICALS INC | -2.4% |